These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9086182)

  • 1. Protective effect of a novel free radical scavenger, OPC-14117, on wobbler mouse motor neuron disease.
    Abe K; Morita S; Kikuchi T; Itoyama Y
    J Neurosci Res; 1997 Apr; 48(1):63-70. PubMed ID: 9086182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone restores retrograde labeling of cervical motoneurons in Wobbler mouse motoneuron disease.
    Gonzalez Deniselle MC; Garay L; Gonzalez S; Guennoun R; Schumacher M; De Nicola AF
    Exp Neurol; 2005 Oct; 195(2):518-23. PubMed ID: 16095593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection: blockade of motor neuron death in the wobbler mouse.
    Vergani L; Losa M; Lesma E; Di Giulio AM; Torsello A; Müller EE; Gorio A
    Neuroscience; 1999; 93(2):565-72. PubMed ID: 10465440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edaravone, a Free Radical Scavenger, Delayed Symptomatic and Pathological Progression of Motor Neuron Disease in the Wobbler Mouse.
    Ikeda K; Iwasaki Y
    PLoS One; 2015; 10(10):e0140316. PubMed ID: 26469273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The progesterone receptor agonist Nestorone holds back proinflammatory mediators and neuropathology in the wobbler mouse model of motoneuron degeneration.
    Meyer M; Gonzalez Deniselle MC; Garay L; Sitruk-Ware R; Guennoun R; Schumacher M; De Nicola AF
    Neuroscience; 2015 Nov; 308():51-63. PubMed ID: 26349009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of creatine monohydrate retards progression of motor neuron disease in the wobbler mouse.
    Ikeda K; Iwasaki Y; Kinoshita M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1(3):207-12. PubMed ID: 11464954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of ultra-high dose methylcobalamin in wobbler mouse model of amyotrophic lateral sclerosis.
    Ikeda K; Iwasaki Y; Kaji R
    J Neurol Sci; 2015 Jul; 354(1-2):70-4. PubMed ID: 25982504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of basic fibroblast growth factor on wobbler mouse motor neuron disease.
    Ikeda K; Iwasaki Y; Tagaya N; Shiojima T; Kobayashi T; Kinoshita M
    Neurol Res; 1995 Dec; 17(6):445-8. PubMed ID: 8622800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin treatment attenuates motor neuron degeneration in wobbler mice.
    Iwamoto K; Yoshii Y; Ikeda K
    Amyotroph Lateral Scler; 2009; 10(5-6):405-9. PubMed ID: 19922131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine-free brain-derived neurotrophic factor in wobbler mouse motor neuron disease: dose-related effects and comparison with the methionyl form.
    Ishiyama T; Ogo H; Wong V; Klinkosz B; Noguchi H; Nakayama C; Mitsumoto H
    Brain Res; 2002 Jul; 944(1-2):195-9. PubMed ID: 12106680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of [3H]D-aspartate induced by K+-stimulation is increased in the cervical spinal cord of the wobbler mouse: a model of motor neuron disease.
    Bonanno G; Fumagalli E; Milanese M; Zappettini S; Mennini T
    Neurochem Int; 2009 Sep; 55(5):302-6. PubMed ID: 19576518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of lower motor neuron degeneration in wobbler mice by N-acetyl-L-cysteine.
    Henderson JT; Javaheri M; Kopko S; Roder JC
    J Neurosci; 1996 Dec; 16(23):7574-82. PubMed ID: 8922414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-588, a novel neuroprotective agent, delays progression of neuromuscular dysfunction in wobbler mouse motoneuron disease.
    Ikeda K; Iwasaki Y; Kinoshita M; Marubuchi S; Ono S
    Brain Res; 2000 Mar; 858(1):84-91. PubMed ID: 10700601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of IGF-I and glycosaminoglycans greatly delays motor neurone disease and affects IGF-I expression in the wobbler mouse: a long-term study.
    Gorio A; Lesma E; Madaschi L; Di Giulio AM
    J Neurochem; 2002 Apr; 81(1):194-202. PubMed ID: 12067233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease.
    Gonzalez Deniselle MC; López-Costa JJ; Saavedra JP; Pietranera L; Gonzalez SL; Garay L; Guennoun R; Schumacher M; De Nicola AF
    Neurobiol Dis; 2002 Dec; 11(3):457-68. PubMed ID: 12586554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.
    Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S
    Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular basis of steroid neuroprotection in the wobbler mouse, a genetic model of motoneuron disease.
    González Deniselle MC; González SL; De Nicola AF
    Cell Mol Neurobiol; 2001 Jun; 21(3):237-54. PubMed ID: 11569536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of caspase-dependent apoptosis in spinal motor neurons of the wobbler mouse.
    Bigini P; Atzori C; Fumagalli E; Cagnotto A; Barbera S; Migheli A; Mennini T
    Neurosci Lett; 2007 Oct; 426(2):106-10. PubMed ID: 17890007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in Wobbler mice.
    Dave KR; Prado R; Busto R; Raval AP; Bradley WG; Torbati D; Pérez-Pinzón MA
    Neuroscience; 2003; 120(1):113-20. PubMed ID: 12849745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease.
    Ikeda K; Klinkosz B; Greene T; Cedarbaum JM; Wong V; Lindsay RM; Mitsumoto H
    Ann Neurol; 1995 Apr; 37(4):505-11. PubMed ID: 7717687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.